<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr22-1759720X20947296">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sanchez-Pernaute</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Romero-Bueno</surname>
    <given-names>FI</given-names>
   </name>
   <name>
    <surname>Selva-Oâ€™Callaghan</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia</article-title>. 
  <source>Reumatol Clin</source>. Epub ahead of print 
  <day>16</day>
  <month>4</month>
  <year>2020</year> DOI: 
  <pub-id pub-id-type="doi">10.1016/j.reuma.2020.03.001.</pub-id>
 </mixed-citation>
</ref>
